TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without Progranulin mutations

Harro Seelaar1, H Jurgen Schelhaas, Asma Azmani

  • 1Department of Neurology, Erasmus University Medical Centre, Rotterdam, The Netherlands.

Insights

Frontotemporal dementia with motor neuron disease (FTD + MND) shows significant clinical variation within families. Neuropathological analysis revealed TDP-43 protein inclusions in affected brain tissues, suggesting a shared pathology.

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Frontotemporal dementia (FTD) co-occurs with motor neuron disease (MND) in approximately 10% of cases (FTD + MND).
  • Clinicopathological overlap is suggested by familial aggregation and ubiquitin-positive inclusions in FTD and MND.
  • Genetic loci and defects vary among familial forms.

Purpose of the Study:

  • To investigate the familial aggregation and clinical presentation of FTD + MND in a large Dutch cohort.
  • To examine neuropathological findings, including TDP-43 protein, in familial FTD + MND cases.

Main Methods:

  • Studied 368 FTD patients in The Netherlands for familial FTD + MND.
  • Conducted immunohistochemistry on brain tissue using ubiquitin, p62, and TDP-43 antibodies.
  • Screened for mutations in candidate genes (SOD1, dynactin, angiogenin, MAPT, VCP, progranulin).

Main Results:

  • Identified eight patients from six families with a history of FTD + MND (mean onset 53.2 years).
  • Observed significant interfamilial clinical variation, with presentations including behavioral changes, cognitive decline, and motor neuron disease.
  • Found neuronal cytoplasmic inclusions (NCI) and neuronal intranuclear inclusions (NII) in brain tissue, with TDP-43 staining these inclusions.
  • No mutations were found in screened candidate genes.
  • TDP-43-positive glial inclusions were observed in one case.

Conclusions:

  • Familial FTD + MND exhibits considerable clinical variability, potentially influenced by genetic or environmental factors.
  • Neuronal intranuclear inclusions are present in some familial FTD + MND cases, even without progranulin mutations.
  • The significance of glial TDP-43 inclusions requires further investigation.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...